MedTrace Logo

Community Intervention and Demonstration Area Construction

NCT05715424 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000000

Last updated 2024-04-09

No results posted yet for this study

Summary

The objective of this intervention study was to understand the visual health status of nearly one million children and adolescents in ten provinces in China, and then to conduct intervention and evaluate the effect of intervention measures with the development of myopia as the outcome indicator. The study will be conducted in the form of a stepped intervention and will answer the following questions.

Current China children and adolescent's vision health, including the different degrees of myopia prevalence, and farsightedness reserve status. To evaluate the implementation and effect of eight appropriate technologies and six interventions developed in this study, to reduce the incidence of myopia among children and adolescents in China, to achieve the purpose of nationwide application.

In the early stage of this study, a baseline survey will be conducted on participants. In the middle stage, participants will be required to adjust the seat height regularly and increase the time for outdoor activities, etc. In the later stage, intervention measures will be evaluated based on the overall research situation to consider national promotion.

Conditions

  • Myopia
  • Refractive Errors

Interventions

OTHER

Six interventions for children and adolescents

* Vision Health Record Establishment and Myopia Risk Assessment. * Evaluation of vision care behavior and development of reasonable eye use behavior. * Health education for teachers and parents. * Action to improve the reading and writing environment at home and school. * One hour of outdoor activities in and out of school during the day. * Myopia grading management and medical correction action.

Sponsors & Collaborators

  • Shanghai Eye Disease Prevention and Treatment Center

    collaborator OTHER

  • Beijing Center for Disease Control and Prevention

    collaborator OTHER_GOV

  • Anhui Medical University

    lead OTHER

Principal Investigators

  • FangBiao Tao, Professor · Anhui Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05715424 on ClinicalTrials.gov